Pharsight

Drugs that contain Alcaftadine

1. List of Lastacaft drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10617695 ALLERGAN Ophthalmic compositions containing alcaftadine
Mar, 2027

(3 years from now)

US8664215 ALLERGAN Ocular allergy treatments with alcaftadine
Dec, 2027

(4 years from now)

Market Authorisation Date: 28 July, 2010

Treatment: Use of lastacaft to temporary relieve itchy eyes due to pollen, ragweed, grass, animal hair and dander

Dosage: SOLUTION/DROPS;OPHTHALMIC

How can I launch a generic of LASTACAFT before it's patent expiration?
More Information on Dosage

LASTACAFT family patents

9

United States

3

Japan

2

Denmark

2

Argentina

2

Spain

2

Poland

2

Taiwan, Province of China

2

China

2

European Union

1

Israel

1

South Africa

1

Mexico

1

Australia

1

Jordan

1

Hong Kong

1

Uruguay

1

Norway

1

Costa Rica

1

Singapore

1

Brazil

1

Malaysia

1

Korea, Republic of

1

Peru

1

Chile

1

Ecuador

1

Nicaragua

1

Ukraine

EA

1

EA

1

Canada

1

New Zealand

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic